Clinical Trial Update: A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS) [Phase 2]

View source ↗

Summary

A Phase 2 dose-ranging clinical trial of TTI-0102 in adults and children with Leigh syndrome spectrum is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leigh Syndrome

Drugs mentioned

• TTI-0102

Snippet

Sponsor: Thiogenesis Therapeutics, Inc. | Conditions: Leigh Syndrome | Phase 2 | Status: NOT_YET_RECRUITING